Drug Report History #276032
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v5-EN | Version v4-FR |
|---|---|---|
| Language | English (Updated) | French |
| Date Updated | 2026-03-17 (Updated) | 2026-02-03 |
| Drug Identification Number | 02409968 | 02409968 |
| Brand name | CEFTRIAXONE FOR INJECTION | CEFTRIAXONE FOR INJECTION |
| Common or Proper name | CefTRIAXone for Injection 100 g, SmartPak® | CefTRIAXone for Injection 100 g, SmartPak® |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | CEFTRIAXONE | CEFTRIAXONE |
| Strength(s) | 100G | 100G |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 100 g | 100 g |
| Anatomical Therapeutical Chemical (ATC) code | J01DD | J01DD |
| Anatomical Therapeutical Chemical (ATC) description | OTHER BETA-LACTAM ANTIBACTERIALS | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2026-03-01 | 2026-03-01 |
| Actual start date | ||
| Estimated end date | 2026-05-15 | 2026-05-15 |
| Actual end date | ||
| Shortage status | Actual shortage (Updated) | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Fresenius Kabi Canada regrets to advise that due to further production delays, we will be extending the backorder on our Ceftriaxone for Injection, 100 g Bag, until May 15, 2026. | Fresenius Kabi Canada regrets to advise that due to further production delays, we will be extending the backorder on our Ceftriaxone for Injection, 100 g Bag, until May 15, 2026. |
| Health Canada comments |